Results 31 to 40 of about 1,176 (175)

Intracholecystic Papillary Neoplasm With Associated Invasive Carcinoma, Accompanied by Tumor Thrombi of Hepatoid Adenocarcinoma: A Case Report. [PDF]

Case Rep Pathol
Hepatoid adenocarcinoma (HAC) is a rare extrahepatic adenocarcinoma characterized by hepatocellular differentiation. HAC arising in the gallbladder is rare. We report a case of intracholecystic papillary neoplasm (ICPN) with HAC, most of which were tumor thrombi.
Yoshida S, Kouchi Y, Eto R, Ohtsuka M, Kishimoto T.   +4 more
europepmc   +2 more sources

Approach to the Diagnosis of Hepatoid Adenocarcinoma, an Under-reported Entity: Case Series and Review of Literature

Asian Journal of Oncology, 2022
Hepatoid adenocarcinoma is a rare type of extra-hepatic adenocarcinoma which exhibits morphological, functional, and immunohistochemical features of hepatocellular carcinoma, hence correct diagnosis poses a challenge. The most frequent site of this tumor
Prerna Chhabra, Sankalp Sancheti, Akash Pramod Sali, Puneet Kaur Somal, Aishwarya Sharma, Rahat Singh Brar, Ashish Gulia, Rakesh Kapoor   +7 more
doaj   +1 more source

Hepatoid adenocarcinoma of the lung [PDF]

QJM, 2016
Learning Point for Clinicians Hepatoid adenocarcinoma of lung is a rare type of lung cancer which is defined as an α-fetoprotein—producing primary carcinoma with morphological features similar to hepatocellular carcinoma. Establishing the diagnosis of HAL is worthwhile because of the potential for altered management. A 79-year-old Chinese male smoker
G-Q, Qian, F-Y, Yin, G-X, Li, J-G, Chu
openaire   +2 more sources

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer

Cancer Communications, Volume 43, Issue 12, Page 1312-1325, December 2023., 2023
Abstract Background Circulating tumor DNA (ctDNA) is a promising biomarker for predicting relapse in multiple solid cancers. However, the predictive value of ctDNA for disease recurrence remains indefinite in locoregional gastric cancer (GC). Here, we aimed to evaluate the predictive value of ctDNA in this context.
Shu‐Qiang Yuan, Run‐Cong Nie, You‐Sheng Huang, Ying‐Bo Chen, Si‐Yu Wang, Xiao‐Wei Sun, Yuan‐Fang Li, Ze‐Kun Liu, Yan‐Xing Chen, Yi‐Chen Yao, Yu Xu, Hai‐Bo Qiu, Yao Liang, Wei Wang, Ze‐Xian Liu, Qi Zhao, Rui‐Hua Xu, Zhi‐Wei Zhou, Feng Wang   +18 more
wiley   +1 more source

Primary hepatoid adenocarcinoma of the lung in Yungui Plateau, China: A case report. [PDF]

World J Clin Cases, 2019
Hepatoid adenocarcinoma (HAC) occurs in extrahepatic organs such as the gastrointestinal tract, testes, ovaries, lungs, mediastinum and pancreas, and frequently produces α-fetoprotein (AFP). HAC of the lung (HAL) is rare, characterized by difficult treatment and poor prognosis.
Shi YF, Lu JG, Yang QM, Duan J, Lei YM, Zhao W, Liu YQ.   +6 more
europepmc   +3 more sources

Hepatoid carcinoma of the pancreas [PDF]

, 2015
BACKGROUND: Hepatoid carcinoma of the pancreas is extremely rare. This article tries to summarize the clinical features and outcomes of pancreatic hepatoid carcinoma.
Po-Chung Kuo, Rheun-Chuan Lee, Shih-Chin Chen, Shin-E Wang, Yi-Ming Shyr, Ying-Ju Kuo   +5 more
core   +1 more source

SALL4 as an indicator for the diagnosis of hepatoid carcinoma of the ovary: A case report and literature review

Clinical Case Reports, Volume 11, Issue 8, August 2023., 2023
Key Clinical Message Primary HCO is a rare, aggressive ovarian malignant tumor, morphologically resembling HCC. SALL4 can be adopted to differentiate HCO from HCC. The serum AFP and CA125 rather than HE4 can be employed as possible biomarkers to track treatment and monitor recurrence.
Jiana Li, Xiaohua Wu
wiley   +1 more source

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors

Thoracic Cancer, Volume 14, Issue 12, Page 1102-1117, April 2023., 2023
Abstract Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete surgical resection is recommended.
Chunwei Xu, Yongchang Zhang, Wenxian Wang, Qian Wang, Ziming Li, Zhengbo Song, Jiandong Wang, Jinpu Yu, Jingjing Liu, Shirong Zhang, Xiuyu Cai, Ming Wu, Ping Zhan, Hongbing Liu, Tangfeng Lv, Liyun Miao, Lingfeng Min, Jiancheng Li, Baogang Liu, Jingping Yuan, Zhansheng Jiang, Gen Lin, Xiaohui Chen, Xingxiang Pu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Chengzhi Zhou, Junping Zhang, Hui Guo, Qian Chu, Rui Meng, Xuewen Liu, Jingxun Wu, Xiao Hu, Min Fang, Jin Zhou, Zhengfei Zhu, Xiaofeng Chen, Weiwei Pan, Fei Pang, Yuxiang Zhou, Qijie Jian, Kai Wang, Liping Wang, Youcai Zhu, Guocai Yang, Xinqing Lin, Jing Cai, Lijun Liang, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Jianhui Huang, Yinbin Zhang, Pingli Sun, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Yue Hao, Zhen Wang, Bing Wan, Donglai Lv, Genhua Yu, Anna Li, Jin Kang, Jiatao Zhang, Chao Zhang, Huafei Chen, Lin Shi, Leiguang Ye, Gaoming Wang, Yina Wang, Feng Gao, Wei Zhou, Chunxiu Hu, Jianguo Wei, Bihui Li, Zhongwu Li, Yuan Li, Zhefeng Liu, Nong Yang, Lin Wu, Qiming Wang, Wenbin Huang, Zhuan Hong, Guansong Wang, Meiyu Fang, Yong Fang, Xixu Zhu, Kaiqi Du, Jiansong Ji, Yi Shen, Yiping Zhang, Shenglin Ma, Yong Song, Yuanzhi Lu, Anwen Liu, Wenfeng Fang, Wenzhao Zhong   +107 more
wiley   +1 more source

Primary hepatoid adenocarcinoma of the lung: A study of two cases with review of literature

Indian Journal of Medical and Paediatric Oncology, 2020
Primary hepatoid adenocarcinoma (HAC) is a rare extrahepatic adenocarcinoma with morphological and phenotypical resemblance to hepatocellular carcinoma (HCC).
Ashwini Nargund, Mohit Agrawal, Priya Dharmalingam, Usha Amirtham, Malathi MukundaPai   +4 more
doaj   +1 more source

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series [PDF]

Cancer Med
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Liava C, Venkatesh S, Torbenson M, Kamath P, Hilscher M.   +4 more
europepmc   +2 more sources